Continuously evolving venues, methods, and targets of patent litigation; the new USPTO director; patent reform bills … these are just a few factors challenging Japanese IP executives’ already complex task of trying to manage their global IP footprint smarter.
In this half-day, complimentary seminar, former USPTO Director Jon W. Dudas and a group of U.S., Japanese, and Chinese IP attorneys experienced in advising Japanese corporations decipher what really matters for Japanese businesses as U.S. patent procurement and enforcement regimes are being radically restructured. The topics included:
- The New Administration and Director Kappos – What Happens Next?
- The effect on the Patent Reform Act of 2009
- What will become of the Tafas v. Doll rules package and the interpretation of Bilski?
- How might the rules on inter partes reexamination be tightened?
- Strategic Use of Inter Partes Reexamination in Patent Litigation
- In synergy with expected procedural changes under the new USPTO director, the very high kill ratio of patents makes inter partes reexamination a very attractive alternative or parallel to district court litigation
- Pros and cons vs. alternatives
- Mistakes to avoid
- Strategic Measures for Effective and Efficient U.S. Patent Litigation
- Focused discovery, management controls, and other tactical measures to achieve litigation goals without undue costs
- Positioning a company to exit litigation early
- Latest considerations for transferring away from certain “Rocket Dockets”
- Chinese Infringement Under the Third Amendment:
- Milestones for claim and patent application drafting and claim interpretation based on the draft interpretation of patent infringement principles issued by the highest court in China
- Comparative analyses of the Chinese patent law with reference to Japanese and U.S. patent principles
Guest Speakers
- Dr. Hiroshi Akimoto, former Managing Director, Takeda Pharmaceutical Company, Ltd.
- Shozo Uemura, former Deputy Director General, WIPO
Foley Speakers
- Jon W. Dudas, former Director of USPTO and Partner, IP Litigation
- Pavan K. Agarwal, Partner and Chair, Electronics
- Etsuo Doi, Partner, Electronics, Tokyo
- Stephen B. Maebius, Partner and Co-Chair, Life Sciences Industry Team
- Prof. Harold C. Wegner, Partner, Chemical & Pharmaceutical
- Yan Zhao, Senior Counsel, Electronics, Shanghai
For specific information on the content of this seminar, contact Konomi Kaji at [email protected].
People
Related Insights
07 February 2025
Health Care Law Today
The Colorado AI Act: Implications for Health Care Providers
Artificial intelligence (AI) is increasingly being integrated into health care operations, from administrative functions such as scheduling and billing to clinical decision-making, including diagnosis and treatment recommendations. Although AI offers significant benefits, concerns regarding bias, transparency, and accountability have prompted regulatory responses.
07 February 2025
Trump Tariffs 2.0: FAQs on How Your Contract Comes into Play
Video FAQ: Does your contract protect you? The Trump administration’s tariffs have reshaped global trade—but how do they impact your contracts? From force majeure to price adjustment clauses, understanding these provisions is critical for protecting your business.
05 February 2025
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.